Answers for covered entities
and pharmacies.

We stay involved throughout the relationship. We review eligible claims, submission status, manufacturer responses, denials, reported payments and outstanding balances. We document what needs attention, coordinate follow-up and provide ongoing reporting so your staff does not have to manage each step alone.

No. We work alongside your TPA, Beacon and other authorized sources. We review the records across those systems, identify gaps and give your team a clear reconciliation and follow-up layer.

We review the stated reason and supporting records, identify missing or inconsistent information, document the issue and coordinate the appropriate correction, resubmission or escalation. Your portal keeps the status and next action visible.

We keep estimated, submitted, reported-paid and outstanding amounts separate. When appropriate evidence is available, we match the reported payment to remittance or ACH information and keep unresolved differences visible.

Yes. We review qualification, capture and replenishment data, compare available records and reporting, identify gaps and explain which workflows need action. We continue monitoring and reporting as part of the ongoing relationship.

Yes. We can review MFP reconciliation for covered-entity-owned pharmacies as a separate workflow. We match eligible pharmacy fills with MTF and manufacturer records, review 340B-related adjustments, identify missing or delayed refunds and coordinate follow-up.

A pharmacy participates through an arrangement with an eligible covered entity. We help evaluate partnership fit, model the opportunity, prepare outreach and clarify the operational and financial responsibilities before an agreement is signed.

We use available pharmacy and covered-entity data to model projected volume, dispensing fees, inventory effects and potential value. We then explain the assumptions and help you evaluate the full economics of the relationship.

Moving purchases from a retail account to a covered entity’s 340B account can change wholesaler or retail rebate calculations. We evaluate that impact alongside dispensing fees, inventory cost, cash flow and the full economics of the arrangement.

340B replenishment can affect ordering, inventory timing and cash flow. We review replenishment patterns, duplicate-purchase risk and purchasing workflows, then continue monitoring the areas that need attention.

Yes. We provide ongoing program management, including workflow review, TPA reporting, manufacturer restrictions, documentation, performance monitoring and issue follow-up. We stay with your pharmacy and handle the recurring work defined in the engagement.

Yes. We review dispensing fees, financial terms, responsibilities, reporting and operational requirements. We organize negotiation priorities and partner questions, help move discussions forward and remain involved through follow-up.

Yes. We can reconcile available pharmacy, MTF and manufacturer records, distinguish 340B-related adjustments from other discrepancies, identify missing or delayed refunds and coordinate the appropriate inquiry and follow-up.